Alembic Pharmaceuticals Ltd received final approval from the US health regulator for generic Dabigatran Etexilate capsules 75 mg and 150 mg to reduce stroke and blood clots in adults with a specific medical condition.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/9PYGBh2
via IFTTT
No comments:
Post a Comment